High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer.

Eleftherios Vairaktaris, Zoe Serefoglou, Christos Yapijakis, Antonis Vylliotis, Emeka Nkenke, Spyridoula Derka, Stavros Vassiliou, Dimitrios Avgoustidis, Friedrich Wilhelm Neukam, Efstratios Patsouris

PubMed · 2007 · 49 citations · 26 references

Concepts

Abstract

BACKGROUND: In the light of the recently found contribution of matrix metalloproteinases (MMPs) to oral oncogenesis, the correlation of MMP-7 with risk for oral cancer was investigated. MATERIALS AND METHODS: The MMP-7 -181A/G polymorphism in 159 German and Greek patients with oral squamous cell carcinoma and 120 healthy controls of equivalent gender and ethnicity was studied. RESULTS: The detected carrier frequency of the high expression G allele was significantly higher in patients compared to controls (74.8% versus 61.7%, p = 0.0257). This significant difference was more pronounced in patients with early stages of cancer and absent in those with advanced stages. A/G heterozygotes have a double relative risk (OR 2.07, 95%, CI 1.17-3.67) of developing early stages of oral cancer than low expression A/A homozygotes. CONCLUSION: MMP-7 gene expression is associated with increased risk only for early stages of oral cancer, possibly due to the inhibitory effect of MMP-7 in angiogenesis.

References

26